Thaçi, D.; Armstrong, A.; Lebwohl, M.; Blauvelt, A.; Paul, C.; Puig, L.; Wang, M.; Vanvoorden, V.; Madden, C.; Wiegratz, S.; Deherder, D.; Gordon, K. Maintenance of Bimekizumab Efficacy through 2 Years in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3/3b Trials. J of Skin 2022, 6, s71.